Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline after dacryocystorhinostomy for postoperative congestion
ACTRN12619001394134Phase 2Completed
- Sponsor
- Philippine General Hospital
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxymetazoline in dacryostenosis (2 arms), sponsored by Philippine General Hospital. Primary endpoint: Fistula patency by lacrimal irrigation. Started Jun 2017; status: completed.
02
Drugs
oxymetazoline
03
Conditions
dacryostenosis
Beyond the preview
Go deeper on ACTRN12619001394134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001394134.